← All Sponsors
SPONSOR

GELLC (Grupo Español de Leucemia Linfocítica Crónica)

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Richter Syndrome
NCT06926205 Phase 2
Recruiting

CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL

Richter Syndrome
Spain View Trial →